ATE128030T1 - Antiallergische mischung. - Google Patents
Antiallergische mischung.Info
- Publication number
- ATE128030T1 ATE128030T1 AT91112577T AT91112577T ATE128030T1 AT E128030 T1 ATE128030 T1 AT E128030T1 AT 91112577 T AT91112577 T AT 91112577T AT 91112577 T AT91112577 T AT 91112577T AT E128030 T1 ATE128030 T1 AT E128030T1
- Authority
- AT
- Austria
- Prior art keywords
- combinations
- antiallergic
- blend
- relates
- allergic reactions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000003266 anti-allergic effect Effects 0.000 title 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 abstract 1
- 239000003848 thrombocyte activating factor antagonist Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56174390A | 1990-08-02 | 1990-08-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE128030T1 true ATE128030T1 (de) | 1995-10-15 |
Family
ID=24243252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91112577T ATE128030T1 (de) | 1990-08-02 | 1991-07-26 | Antiallergische mischung. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0469477B1 (de) |
| JP (1) | JPH04244028A (de) |
| AT (1) | ATE128030T1 (de) |
| AU (1) | AU651358B2 (de) |
| CA (1) | CA2048236A1 (de) |
| DE (1) | DE69113162T2 (de) |
| DK (1) | DK0469477T3 (de) |
| IE (1) | IE70332B1 (de) |
| NZ (1) | NZ239201A (de) |
| ZA (1) | ZA916036B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993017709A1 (fr) * | 1992-03-12 | 1993-09-16 | Ono Pharmaceutical Co., Ltd. | Agent antiprurigineux |
| US6911462B2 (en) | 1998-05-22 | 2005-06-28 | Avanir Pharmaceuticals | Benzimidazole compounds for regulating IgE |
| US6303645B1 (en) | 1998-05-22 | 2001-10-16 | Avanir Pharmaceuticals | Benzimidazole derivatives as modulators of IgE |
| IL139828A0 (en) * | 1998-05-22 | 2002-02-10 | Avanir Pharmaceuticals | COMPOUNDS HAVING IgE AFFECTING PROPERTIES |
| US6369091B1 (en) | 1998-05-22 | 2002-04-09 | Avanir Pharmaceuticals | Benzimidazole analogs as down-regulators of IgE |
| US6919366B2 (en) | 1998-05-22 | 2005-07-19 | Avanir Pharmaceuticals | Benzimidazole derivatives as modulators of IgE |
| CA2441177A1 (en) | 2001-03-12 | 2002-09-19 | Avanir Pharmaceuticals | Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
| DK1482973T3 (da) * | 2002-03-15 | 2009-12-07 | Schering Corp | Fremgangsmåde til modulering af CD200-receptorer |
| TWI276631B (en) | 2002-09-12 | 2007-03-21 | Avanir Pharmaceuticals | Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
| AU2003270426A1 (en) | 2002-09-12 | 2004-04-30 | Avanir Pharmaceuticals | PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68904475T2 (de) * | 1988-04-27 | 1993-05-13 | Schering Corp | Gewisse paf-antagonist/antihistamin-mischungen und verfahren. |
-
1991
- 1991-07-26 AT AT91112577T patent/ATE128030T1/de not_active IP Right Cessation
- 1991-07-26 EP EP91112577A patent/EP0469477B1/de not_active Expired - Lifetime
- 1991-07-26 DE DE69113162T patent/DE69113162T2/de not_active Expired - Fee Related
- 1991-07-26 DK DK91112577.1T patent/DK0469477T3/da active
- 1991-07-31 ZA ZA916036A patent/ZA916036B/xx unknown
- 1991-07-31 CA CA002048236A patent/CA2048236A1/en not_active Abandoned
- 1991-07-31 NZ NZ239201A patent/NZ239201A/en unknown
- 1991-08-01 JP JP3216009A patent/JPH04244028A/ja active Pending
- 1991-08-01 IE IE273991A patent/IE70332B1/en not_active IP Right Cessation
- 1991-08-01 AU AU81535/91A patent/AU651358B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IE912739A1 (en) | 1992-02-12 |
| DE69113162D1 (de) | 1995-10-26 |
| EP0469477A1 (de) | 1992-02-05 |
| JPH04244028A (ja) | 1992-09-01 |
| EP0469477B1 (de) | 1995-09-20 |
| IE70332B1 (en) | 1996-11-13 |
| DE69113162T2 (de) | 1996-03-14 |
| ZA916036B (en) | 1992-05-27 |
| AU651358B2 (en) | 1994-07-21 |
| AU8153591A (en) | 1992-02-13 |
| DK0469477T3 (da) | 1995-12-27 |
| CA2048236A1 (en) | 1992-02-03 |
| NZ239201A (en) | 1994-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1068870T3 (da) | Antitumormidler | |
| PT1005271E (pt) | Composicao biocida sinergica | |
| FI964218A0 (fi) | Yhdisteitä, joilla on verenpainetta alentavia, sydäntä suojaavia, verettömyyttä vastustavia ja rasvaa hajottavia ominaisuuksia | |
| BR9106438A (pt) | Composicoes terapeuticas sinergisticas e processos | |
| FI953748A0 (fi) | Yhdisteitä, joilla on sekä voimakas kalsium antagonisti- että antioksidanttiaktiivisuus sekä niiden käyttö solua suojaavina aineina | |
| NO944377D0 (no) | Kjölemiddelblandinger | |
| DE68913792D1 (de) | Synergistische antimikrobielle Zusammensetzung. | |
| DE69420736D1 (de) | Zusätze und kraftstoffzusammensetzungen | |
| ATE403430T1 (de) | Neue carbamate- und harnstoffderivate als mittel gegen multidrugresistenz | |
| DE69519672D1 (de) | Synergistische tensidzusammensetzungen und konzentrate davon zur feuerbekämpfung | |
| DK0889886T5 (da) | Hidtil ukendte, i 6-stilling substituerede phenanthridiner | |
| ATE128030T1 (de) | Antiallergische mischung. | |
| NZ513096A (en) | Compositions for treating inflammatory response | |
| DE69322912D1 (de) | Kosmetisches und/oder Nahrungsmittel enthaltend eine nicht-verseifbare Fraktion von Sesamöl und Vitamin-E | |
| ATE381327T1 (de) | Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis | |
| DE69432985D1 (de) | Synergistische anthelmintische zusammensetzungen gegen fasciola hepatica und andere fascola spezien | |
| ATE45286T1 (de) | Gammainterferon und lymphotoxin enthaltende synergistische zusammensetzung und ihre herstellung. | |
| FI961380A7 (fi) | Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitam iseksi | |
| NO20012631D0 (no) | Trebevarende formuleringer | |
| FI944011A0 (fi) | Koostumus tukkituotteiden suojaamiseksi | |
| BR9406244A (pt) | Composições sinergisticas contendo antelminticos de benzimidazol e compostos de metilenodioxifenila | |
| DE69226652D1 (de) | Blendschutz und reflexionsfreie zusammensetzung | |
| BE882989A (fr) | Compositions fongicides synergiques | |
| FI934360A7 (fi) | Benflumetolia sisältävät synergistiset malarialääkekoostumukset | |
| IT8467688A1 (it) | Composizioni fungicide sinergistiche. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |